Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance.

The British journal of surgery - 3 Jan 2024

Onnekink Anke M, Michiels Nynke, Klatte Derk C F, Oldenburg Lotte, Mieog J Sven D, Vahrmeijer Alexander L, van Hooft Jeanin E, van Leerdam Monique E, Bonsing Bert A

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin-Dependent Kinase Inhibitor p16
Share to Genetic Predisposition to Disease
Share to Germ-Line Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Pancreatic Neoplasms

Share to Treatment Outcome

Source

Identifiers

PMID: 38156443
DOI: 10.1093/bjs/znad430

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance.PMID 38156443Read ↗

Treatment opportunities and future perspectives for pancreatic cancer patients with germline BRCA1-2 pathogenic variantsSemantic proximity Read ↗

Reduced survival in patients with ductal pancreatic adenocarcinoma associated with CDKN2 mutation.Semantic proximity Read ↗

Overall survival and clinical characteristics of BRCA mutation carriers with stage I/II pancreatic cancerSemantic proximity Read ↗

The benefit of pancreatic cancer surveillance in carriers of germline BRCA1/2 pathogenic variants.Semantic proximity Read ↗

A prospective observational study of pancreatic cancer risk in men and women with pathogenic variants in BRCA1 or BRCA2Semantic proximity Read ↗

Patients with deleterious germline mutations: A heterogeneous population for pancreatic cancer screening?Semantic proximity Read ↗

Post-operative mortality and recurrence patterns in pancreatic cancer according to KRAS mutation and CDKN2A, p53, and SMAD4 expression.Semantic proximity Read ↗

Prevalence of CDKN2A mutations in pancreatic cancer patients: implications for genetic counseling.Semantic proximity Read ↗

Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk.Semantic proximity Read ↗

Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery.Semantic proximity Read ↗

Durable response to olaparib in pancreatic duct adenocarcinoma with deleterious ARID1A mutation.Semantic proximity Read ↗

Long-term survivors of pancreatic adenocarcinoma show low rates of genetic alterations in KRAS, TP53 and SMAD4.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.